Skip to content
Biodatica
Start free

GORDON RESEARCH CONFERENCES

East Greenwich, RI

OncologyGrant-only
Sign in to watch

What changed

NIH R01 · $0.5M · Targeting early events in prostate cancer lineage plasticity

7mo agoGrant renewalDec 8, 2025Source filing (opens the source filing in a new tab)

Momentum

40no change

Momentum 40 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R13 · $8k · non-dilutive

    Aug 6, 2025

    GORDON RESEARCH CONFERENCES · PI DEHM, SCOTT M. · NCI · award ends Jul 31, 2026 · 2025 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Seminar

    NIH RePORTER · NIH RePORTER 11167047 (opens the source filing in a new tab)

  2. Grant

    R01 · $456k · non-dilutive

    Dec 1, 2022

    UNIVERSITY OF MINNESOTA · PI DEHM, SCOTT M. · NCI · award ends Nov 30, 2027 · Targeting early events in prostate cancer lineage plasticity

    NIH RePORTER · NIH RePORTER 11238520 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources